With COVID boosters expected to cost £100 when they go on sale in UK pharmacies, there are concerns about whether this will put people off getting the jab.
Disiplin ilmiah, gaya jurnalistik
Artikel-artikel mengenai Hybrid immunity
Menampilkan semua artikel
As COVID finds its equilibrium, infection rates will rise and fall, influenced by seasons, school holidays and new subvariants. Managing the risk is complex and needs to be cost effective.
There’s pretty much no one left in the US who hasn’t been exposed to the coronavirus, whether by vaccination, infection or both.
The decision to remove the testing requirement for international arrivals seems shortsighted. All outbreaks in Aotearoa have been caused by new variants coming across the border.
As New Zealand emerges from its Omicron wave, increasing hybrid immunity and access to antivirals mean it’s time to shift the focus of COVID management.
Case numbers are falling in all age groups, including over-70s. This is good news as case rates in older people have been a key driver of the steep rise in hospitalisations and deaths in this wave.
Achieving herd immunity via vaccination was always going to be a hard ask. Now it’s mathematically impossible.
Because COVID-19 is a relatively new virus, researchers still aren’t sure exactly how long vaccines and prior infections provide protection.
Kontributor teratas
-
Professor in Applied Mathematics, University of Canterbury
-
Senior Lecturer, University of Auckland, Waipapa Taumata Rau
-
Professor of Pathology, Microbiology and Immunology, University of South Carolina
-
Professor and Webster Family Chair in Viral Pathogenesis, University of Otago
-
Professor, Department of Women's and Children's Health (Dunedin), University of Otago
-
Medical adviser immunisation, University of Auckland, Waipapa Taumata Rau
-
Associate Professor Immunology and Microbiology and Clinical Microbiologist, University of Otago
-
Associate Professor Primary Health, University of Auckland, Waipapa Taumata Rau
-
Professor of Biology, the Emerging Pathogens Institute, University of Florida
-
Assistant Professor of Biostatistics, University of Florida
-
Professor, epidemiological modelling of infectious diseases, UNSW Sydney
-
Research Fellow, Epidemic Decision Support, The University of Melbourne
-
Professor in Mathematical Biology, The University of Melbourne
-
Associate Professor, Epidemiology, Deakin University
-
Personal Chair of Immunopathology, The University of Edinburgh
